Medidata Solutions to Shape Discussion at 6th Annual E-clinical Trials Conference in London
FOR IMMEDIATE RELEASE
Medidata Solutions to Shape Discussion at 6th Annual
E-clinical Trials Conference in London
Graham Bunn, Vice President of Strategic Alliances, to Present Business Strategies and
Ideas for the Integration and Implementation of E-clinical Systems
NEW YORK, NY – May 16, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Graham Bunn, Vice President of Strategic Alliances, will be speaking at the ViB’s Sixth Annual E-Clinical Trials Conference, to be held May 23–24, 2006 in London. Dr. Bunn will also be participating in a panel of industry experts during the pre-conference workshop to be held on May 22, 2006. This event is designed to address practical ways of efficiently and successfully incorporating electronic systems into clinical trials.
During his presentation, “Re-assessing the Business Drivers and Strategies for the Integration and Implementation of E-Clinical Systems,” on Tuesday, May 23 at 9:10 a.m., Dr. Bunn will outline ideas, motivations and strategies for companies deploying eclinical solutions. As the first speaker of the day one session, “Re-exploring the Objectives and Benefits of Electronic Clinical Systems,” Dr. Bunn will also discuss the ROI that can be achieved by implementing electronic trials and how these technologies can aid in business decisions on projects or outsourcing activities.
On Monday, May 22, Dr. Bunn will participate in the pre-conference workshop, “Optimizing the Process of Efficiency and Cost Effectiveness of an E-Clinical Trial,” led by David Dworaczyk of King Pharmaceuticals. The workshop will include perspective from various pharmaceutical industry thought-leaders and will address the challenges and concerns companies face in EDC implementation procedures.
Dr. Graham Bunn is an industry luminary and early pioneer of EDC technologies, bringing more than 15 years of experience delivering strategic electronic data capture and management solutions to pharmaceutical companies worldwide. He joined Medidata in November of 2005 and is responsible for developing and managing relationships with various partners and supporting the sales and delivery of Medidata products and services in Europe and in other regions. He also plays a leading role in Medidata’s ASPire to Win program in Europe, a non-exclusive application service provider (ASP) partnership and business model which enables CROs to become Medidata Rave-certified and generate new revenue streams through Medidata’s comprehensive electronic clinical technology. Leading CROs including ICON, Kendle and PharmaLinkFHI, have participated the program, which was established January of 2005.
Prior to joining Medidata, Dr. Bunn served as global vice president of e-clinical business development at Quintiles, a leading contract research organization providing a range of pharmaceutical services. After spending 10 years in various IT, business solutions and pre-sales roles at Quintiles in the 1990s, Bunn returned to Quintiles in 2001 to lead its global implementation of EDC technology and develop e-clinical processes.
About ViB and E-Clinical Trials Conference
ViB is the conference arm of the SPG Media Group. ViB events was established over ten years ago and has built a reputation for excellence and currently arranges some thirty European events annually. The 2006 e-Clinical Trials Conference will bring together the experiences of the major pharmaceutical companies to give practical and adaptable examples of incorporating electronic systems into clinical trials. From building and managing a competent global e-system, to upgrading present EDC systems and developing technologies such as ePro and eRecruitment, this highly developed event will provide the tools to successfully run e-clinical systems. For more information, please visit www.vibevents.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions’ broad client base and deep clinical experience provide value for the world’s leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com